Hogan Jacob S, Orav E John, Vapiwala Neha, Lam Miranda B
Harvard Radiation Oncology Program, Massachusetts General Hospital and Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Cancer. 2025 Jan 1;131(1):e35546. doi: 10.1002/cncr.35546. Epub 2024 Sep 4.
More than half of patients with cancer receive radiotherapy, which often requires daily treatments for several weeks. The impact of geographic and sociodemographic factors on the odds of patients with cancer being recommended radiotherapy, starting radiotherapy, and completing radiotherapy is not well understood.
This was a retrospective patient cohort study that included patients diagnosed with one of the 10 most common solid cancers from January 1, 2018, to December 31, 2021, in the National Cancer Database. The primary predictor was radial distance from a patient's home to their cancer treatment hospital. Other covariates included baseline patient characteristics (age, sex, comorbidities, metastatic disease, cancer site), sociodemographic characteristics (race, ethnicity, median income quartile, insurance status), geographic region, and facility type. The three primary outcomes were being recommended radiotherapy, starting recommended radiotherapy, and completing radiotherapy.
Of the 3,068,919 patients included, patients living >50 miles away had lower odds of being recommended radiotherapy than those living <10 miles away. Compared to White patients, Asian and Hispanic patients had lower odds of being recommended radiotherapy, and Black patients had lower odds of starting recommended radiotherapy. Uninsured patients, those with Medicaid or Medicare, and patients in lower median income quartiles had lower odds of starting or completing radiotherapy.
Geographic and sociodemographic factors impact access to radiotherapy at different levels in cancer care and understanding these factors could aid policymakers and practices in identifying and supporting at-risk patients.
超过半数的癌症患者接受放射治疗,而这通常需要持续数周的每日治疗。地理和社会人口统计学因素对癌症患者被推荐接受放射治疗、开始放射治疗以及完成放射治疗几率的影响尚不清楚。
这是一项回顾性患者队列研究,纳入了2018年1月1日至2021年12月31日在国家癌症数据库中被诊断患有10种最常见实体癌之一的患者。主要预测因素是患者住所到其癌症治疗医院的直线距离。其他协变量包括患者基线特征(年龄、性别、合并症、转移性疾病、癌症部位)、社会人口统计学特征(种族、族裔、收入中位数四分位数、保险状况)、地理区域和机构类型。三个主要结局是被推荐接受放射治疗、开始接受推荐的放射治疗以及完成放射治疗。
在纳入的3,068,919名患者中,居住在距离医院超过50英里的患者被推荐接受放射治疗的几率低于居住在距离医院小于10英里的患者。与白人患者相比,亚洲和西班牙裔患者被推荐接受放射治疗的几率较低,而黑人患者开始接受推荐放射治疗的几率较低。未参保患者、有医疗补助或医疗保险的患者以及收入中位数处于较低四分位数的患者开始或完成放射治疗的几率较低。
地理和社会人口统计学因素在癌症治疗的不同层面影响放射治疗可及性,了解这些因素有助于政策制定者和医疗机构识别并支持高危患者。